Jci_page_head_homepage_01 Jci_page_head_homepage_02
Yasunobu Miyake, Kenichi Asano, Hitomi Kaise, Miho Uemura, Manabu Nakayama, Masato Tanaka
Published in Volume 117, Issue 8
J Clin Invest. 2007; 117(8):2268–2278 doi:10.1172/JCI31990
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 3
Administration of apoptotic W3/MOG cells induced antigen-specific T cell unresponsiveness.

(A and B) We intravenously injected 2 × 107 apoptotic W3/MOG-L cells into mice. Three days later, 100 μg of MOG35–55 (A) or KLH (B) in CFA was injected subcutaneously into the bilateral foot pads. Popliteal and inguinal LNs were collected from the mice 5 days after immunization. In vitro, 5 × 105 LN cells were restimulated with MOG35–55 (A) or KLH (B) for 70 hours. T cell proliferation was quantified based on the [3H] thymidine uptake in the last 20 hours of the culture. Mean values are shown with SD. Numbers indicate mouse 1 and mouse 2. (C and D) Apoptotic W3/MOG-L cell injection reduces IFN-γ and IL-17 production in splenocytes. We intravenously injected 2 × 107 apoptotic W3 or W3/MOG-L cells into mice 4 days prior to immunization of MOG35–55 on day 0. Splenocytes obtained 10 days after immunization were restimulated in vitro with MOG35–55 for 72 hours. Production of IFN-γ (C) and IL-17 (D) was measured by ELISA. Mean values are shown with SEM. *P < 0.05. These results are representative of 3 independent experiments.